Global Medical Autologous Biologics Market Growth 2026-2032
The global Medical Autologous Biologics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Medical autologous biologics are therapeutic products derived from a patient"s own cells, tissues, or blood components. The term "autologous" refers to the fact that the source of the biologic material is the individual receiving the treatment. These biologics are personalized medicines, custom-made for each patient, which helps reduce the risk of immune rejection and other complications commonly associated with allogeneic (donor-derived) therapies.
The global market for medical autologous biologics has been experiencing significant growth due to the increasing demand for personalized and regenerative therapies. Autologous biologics offer the advantage of being derived from a patient"s own cells, reducing the risk of immune rejection and adverse reactions. They have found applications in various medical fields, including oncology, orthopedics, cardiovascular diseases, and wound healing. North America, with its well-established healthcare infrastructure and research capabilities, has been a major player in the medical autologous biologics market. European countries have shown increasing interest in regenerative medicine and personalized therapies, driving the adoption of medical autologous biologics. The Asia-Pacific region has seen a surge in research activities and clinical trials focused on autologous biologics, with countries like Japan, China, and South Korea being at the forefront.
LP Information, Inc. (LPI) ' newest research report, the “Medical Autologous Biologics Industry Forecast” looks at past sales and reviews total world Medical Autologous Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Autologous Biologics sales for 2026 through 2032. With Medical Autologous Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Autologous Biologics industry.
This Insight Report provides a comprehensive analysis of the global Medical Autologous Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Autologous Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Autologous Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Autologous Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Autologous Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Autologous Biologics market by product type, application, key manufacturers and key regions and countries.
Medical autologous biologics are therapeutic products derived from a patient"s own cells, tissues, or blood components. The term "autologous" refers to the fact that the source of the biologic material is the individual receiving the treatment. These biologics are personalized medicines, custom-made for each patient, which helps reduce the risk of immune rejection and other complications commonly associated with allogeneic (donor-derived) therapies.
The global market for medical autologous biologics has been experiencing significant growth due to the increasing demand for personalized and regenerative therapies. Autologous biologics offer the advantage of being derived from a patient"s own cells, reducing the risk of immune rejection and adverse reactions. They have found applications in various medical fields, including oncology, orthopedics, cardiovascular diseases, and wound healing. North America, with its well-established healthcare infrastructure and research capabilities, has been a major player in the medical autologous biologics market. European countries have shown increasing interest in regenerative medicine and personalized therapies, driving the adoption of medical autologous biologics. The Asia-Pacific region has seen a surge in research activities and clinical trials focused on autologous biologics, with countries like Japan, China, and South Korea being at the forefront.
LP Information, Inc. (LPI) ' newest research report, the “Medical Autologous Biologics Industry Forecast” looks at past sales and reviews total world Medical Autologous Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Autologous Biologics sales for 2026 through 2032. With Medical Autologous Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Autologous Biologics industry.
This Insight Report provides a comprehensive analysis of the global Medical Autologous Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Autologous Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Autologous Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Autologous Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Autologous Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Autologous Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Adipose Tissue
- Plasma
- Others
Segmentation by Application:
- Hospitals
- Research Center
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vericel Corporation
- BioTime
- Pharmicell
- BrainStorm Cell Therapeutics
- Opexa Therapeutics
- Sartorius
- Neostem
- Dendreon Corporation
- Regenexx
- Cytori Therapeutics
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Autologous Biologics market?
- What factors are driving Medical Autologous Biologics market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Autologous Biologics market opportunities vary by end market size?
- How does Medical Autologous Biologics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Autologous Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Autologous Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Autologous Biologics by Country/Region, 2021, 2025 & 2032
2.2 Medical Autologous Biologics Segment by Type
2.2.1 Adipose Tissue
2.2.2 Plasma
2.2.3 Others
2.2.4 Medical Autologous Biologics Sales by Type
2.2.4.1 Global Medical Autologous Biologics Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Autologous Biologics Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Autologous Biologics Sale Price by Type (2021-2026)
2.3 Medical Autologous Biologics Segment by Application
2.3.1 Hospitals
2.3.2 Research Center
2.3.3 Others
2.3.4 Medical Autologous Biologics Sales by Application
2.3.4.1 Global Medical Autologous Biologics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Medical Autologous Biologics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Medical Autologous Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Autologous Biologics Breakdown Data by Company
3.1.1 Global Medical Autologous Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Medical Autologous Biologics Sales Market Share by Company (2021-2026)
3.2 Global Medical Autologous Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Autologous Biologics Revenue by Company (2021-2026)
3.2.2 Global Medical Autologous Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Medical Autologous Biologics Sale Price by Company
3.4 Key Manufacturers Medical Autologous Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Autologous Biologics Product Location Distribution
3.4.2 Players Medical Autologous Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Medical Autologous Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Autologous Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Autologous Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Autologous Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Autologous Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Autologous Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Autologous Biologics Sales Growth
4.4 APAC Medical Autologous Biologics Sales Growth
4.5 Europe Medical Autologous Biologics Sales Growth
4.6 Middle East & Africa Medical Autologous Biologics Sales Growth
5 AMERICAS
5.1 Americas Medical Autologous Biologics Sales by Country
5.1.1 Americas Medical Autologous Biologics Sales by Country (2021-2026)
5.1.2 Americas Medical Autologous Biologics Revenue by Country (2021-2026)
5.2 Americas Medical Autologous Biologics Sales by Type (2021-2026)
5.3 Americas Medical Autologous Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Autologous Biologics Sales by Region
6.1.1 APAC Medical Autologous Biologics Sales by Region (2021-2026)
6.1.2 APAC Medical Autologous Biologics Revenue by Region (2021-2026)
6.2 APAC Medical Autologous Biologics Sales by Type (2021-2026)
6.3 APAC Medical Autologous Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Autologous Biologics by Country
7.1.1 Europe Medical Autologous Biologics Sales by Country (2021-2026)
7.1.2 Europe Medical Autologous Biologics Revenue by Country (2021-2026)
7.2 Europe Medical Autologous Biologics Sales by Type (2021-2026)
7.3 Europe Medical Autologous Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Autologous Biologics by Country
8.1.1 Middle East & Africa Medical Autologous Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Autologous Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Autologous Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Autologous Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Autologous Biologics
10.3 Manufacturing Process Analysis of Medical Autologous Biologics
10.4 Industry Chain Structure of Medical Autologous Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Autologous Biologics Distributors
11.3 Medical Autologous Biologics Customer
12 WORLD FORECAST REVIEW FOR MEDICAL AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Medical Autologous Biologics Market Size Forecast by Region
12.1.1 Global Medical Autologous Biologics Forecast by Region (2027-2032)
12.1.2 Global Medical Autologous Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Autologous Biologics Forecast by Type (2027-2032)
12.7 Global Medical Autologous Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vericel Corporation
13.1.1 Vericel Corporation Company Information
13.1.2 Vericel Corporation Medical Autologous Biologics Product Portfolios and Specifications
13.1.3 Vericel Corporation Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vericel Corporation Main Business Overview
13.1.5 Vericel Corporation Latest Developments
13.2 BioTime
13.2.1 BioTime Company Information
13.2.2 BioTime Medical Autologous Biologics Product Portfolios and Specifications
13.2.3 BioTime Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioTime Main Business Overview
13.2.5 BioTime Latest Developments
13.3 Pharmicell
13.3.1 Pharmicell Company Information
13.3.2 Pharmicell Medical Autologous Biologics Product Portfolios and Specifications
13.3.3 Pharmicell Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pharmicell Main Business Overview
13.3.5 Pharmicell Latest Developments
13.4 BrainStorm Cell Therapeutics
13.4.1 BrainStorm Cell Therapeutics Company Information
13.4.2 BrainStorm Cell Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.4.3 BrainStorm Cell Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BrainStorm Cell Therapeutics Main Business Overview
13.4.5 BrainStorm Cell Therapeutics Latest Developments
13.5 Opexa Therapeutics
13.5.1 Opexa Therapeutics Company Information
13.5.2 Opexa Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.5.3 Opexa Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Opexa Therapeutics Main Business Overview
13.5.5 Opexa Therapeutics Latest Developments
13.6 Sartorius
13.6.1 Sartorius Company Information
13.6.2 Sartorius Medical Autologous Biologics Product Portfolios and Specifications
13.6.3 Sartorius Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sartorius Main Business Overview
13.6.5 Sartorius Latest Developments
13.7 Neostem
13.7.1 Neostem Company Information
13.7.2 Neostem Medical Autologous Biologics Product Portfolios and Specifications
13.7.3 Neostem Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Neostem Main Business Overview
13.7.5 Neostem Latest Developments
13.8 Dendreon Corporation
13.8.1 Dendreon Corporation Company Information
13.8.2 Dendreon Corporation Medical Autologous Biologics Product Portfolios and Specifications
13.8.3 Dendreon Corporation Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dendreon Corporation Main Business Overview
13.8.5 Dendreon Corporation Latest Developments
13.9 Regenexx
13.9.1 Regenexx Company Information
13.9.2 Regenexx Medical Autologous Biologics Product Portfolios and Specifications
13.9.3 Regenexx Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Regenexx Main Business Overview
13.9.5 Regenexx Latest Developments
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Information
13.10.2 Cytori Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.10.3 Cytori Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cytori Therapeutics Main Business Overview
13.10.5 Cytori Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Autologous Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Autologous Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Autologous Biologics by Country/Region, 2021, 2025 & 2032
2.2 Medical Autologous Biologics Segment by Type
2.2.1 Adipose Tissue
2.2.2 Plasma
2.2.3 Others
2.2.4 Medical Autologous Biologics Sales by Type
2.2.4.1 Global Medical Autologous Biologics Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Autologous Biologics Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Autologous Biologics Sale Price by Type (2021-2026)
2.3 Medical Autologous Biologics Segment by Application
2.3.1 Hospitals
2.3.2 Research Center
2.3.3 Others
2.3.4 Medical Autologous Biologics Sales by Application
2.3.4.1 Global Medical Autologous Biologics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Medical Autologous Biologics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Medical Autologous Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Autologous Biologics Breakdown Data by Company
3.1.1 Global Medical Autologous Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Medical Autologous Biologics Sales Market Share by Company (2021-2026)
3.2 Global Medical Autologous Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Autologous Biologics Revenue by Company (2021-2026)
3.2.2 Global Medical Autologous Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Medical Autologous Biologics Sale Price by Company
3.4 Key Manufacturers Medical Autologous Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Autologous Biologics Product Location Distribution
3.4.2 Players Medical Autologous Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Medical Autologous Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Autologous Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Autologous Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Autologous Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Autologous Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Autologous Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Autologous Biologics Sales Growth
4.4 APAC Medical Autologous Biologics Sales Growth
4.5 Europe Medical Autologous Biologics Sales Growth
4.6 Middle East & Africa Medical Autologous Biologics Sales Growth
5 AMERICAS
5.1 Americas Medical Autologous Biologics Sales by Country
5.1.1 Americas Medical Autologous Biologics Sales by Country (2021-2026)
5.1.2 Americas Medical Autologous Biologics Revenue by Country (2021-2026)
5.2 Americas Medical Autologous Biologics Sales by Type (2021-2026)
5.3 Americas Medical Autologous Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Autologous Biologics Sales by Region
6.1.1 APAC Medical Autologous Biologics Sales by Region (2021-2026)
6.1.2 APAC Medical Autologous Biologics Revenue by Region (2021-2026)
6.2 APAC Medical Autologous Biologics Sales by Type (2021-2026)
6.3 APAC Medical Autologous Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Autologous Biologics by Country
7.1.1 Europe Medical Autologous Biologics Sales by Country (2021-2026)
7.1.2 Europe Medical Autologous Biologics Revenue by Country (2021-2026)
7.2 Europe Medical Autologous Biologics Sales by Type (2021-2026)
7.3 Europe Medical Autologous Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Autologous Biologics by Country
8.1.1 Middle East & Africa Medical Autologous Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Autologous Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Autologous Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Autologous Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Autologous Biologics
10.3 Manufacturing Process Analysis of Medical Autologous Biologics
10.4 Industry Chain Structure of Medical Autologous Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Autologous Biologics Distributors
11.3 Medical Autologous Biologics Customer
12 WORLD FORECAST REVIEW FOR MEDICAL AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Medical Autologous Biologics Market Size Forecast by Region
12.1.1 Global Medical Autologous Biologics Forecast by Region (2027-2032)
12.1.2 Global Medical Autologous Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Autologous Biologics Forecast by Type (2027-2032)
12.7 Global Medical Autologous Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vericel Corporation
13.1.1 Vericel Corporation Company Information
13.1.2 Vericel Corporation Medical Autologous Biologics Product Portfolios and Specifications
13.1.3 Vericel Corporation Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vericel Corporation Main Business Overview
13.1.5 Vericel Corporation Latest Developments
13.2 BioTime
13.2.1 BioTime Company Information
13.2.2 BioTime Medical Autologous Biologics Product Portfolios and Specifications
13.2.3 BioTime Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioTime Main Business Overview
13.2.5 BioTime Latest Developments
13.3 Pharmicell
13.3.1 Pharmicell Company Information
13.3.2 Pharmicell Medical Autologous Biologics Product Portfolios and Specifications
13.3.3 Pharmicell Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pharmicell Main Business Overview
13.3.5 Pharmicell Latest Developments
13.4 BrainStorm Cell Therapeutics
13.4.1 BrainStorm Cell Therapeutics Company Information
13.4.2 BrainStorm Cell Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.4.3 BrainStorm Cell Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BrainStorm Cell Therapeutics Main Business Overview
13.4.5 BrainStorm Cell Therapeutics Latest Developments
13.5 Opexa Therapeutics
13.5.1 Opexa Therapeutics Company Information
13.5.2 Opexa Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.5.3 Opexa Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Opexa Therapeutics Main Business Overview
13.5.5 Opexa Therapeutics Latest Developments
13.6 Sartorius
13.6.1 Sartorius Company Information
13.6.2 Sartorius Medical Autologous Biologics Product Portfolios and Specifications
13.6.3 Sartorius Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sartorius Main Business Overview
13.6.5 Sartorius Latest Developments
13.7 Neostem
13.7.1 Neostem Company Information
13.7.2 Neostem Medical Autologous Biologics Product Portfolios and Specifications
13.7.3 Neostem Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Neostem Main Business Overview
13.7.5 Neostem Latest Developments
13.8 Dendreon Corporation
13.8.1 Dendreon Corporation Company Information
13.8.2 Dendreon Corporation Medical Autologous Biologics Product Portfolios and Specifications
13.8.3 Dendreon Corporation Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dendreon Corporation Main Business Overview
13.8.5 Dendreon Corporation Latest Developments
13.9 Regenexx
13.9.1 Regenexx Company Information
13.9.2 Regenexx Medical Autologous Biologics Product Portfolios and Specifications
13.9.3 Regenexx Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Regenexx Main Business Overview
13.9.5 Regenexx Latest Developments
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Information
13.10.2 Cytori Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
13.10.3 Cytori Therapeutics Medical Autologous Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cytori Therapeutics Main Business Overview
13.10.5 Cytori Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Autologous Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Autologous Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adipose Tissue
Table 4. Major Players of Plasma
Table 5. Major Players of Others
Table 6. Global Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 7. Global Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Table 8. Global Medical Autologous Biologics Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Autologous Biologics Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Autologous Biologics Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Medical Autologous Biologics Sale by Application (2021-2026) & (Kg)
Table 12. Global Medical Autologous Biologics Sale Market Share by Application (2021-2026)
Table 13. Global Medical Autologous Biologics Revenue by Application (2021-2026) & ($ million)
Table 14. Global Medical Autologous Biologics Revenue Market Share by Application (2021-2026)
Table 15. Global Medical Autologous Biologics Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Medical Autologous Biologics Sales by Company (2021-2026) & (Kg)
Table 17. Global Medical Autologous Biologics Sales Market Share by Company (2021-2026)
Table 18. Global Medical Autologous Biologics Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Medical Autologous Biologics Revenue Market Share by Company (2021-2026)
Table 20. Global Medical Autologous Biologics Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Medical Autologous Biologics Producing Area Distribution and Sales Area
Table 22. Players Medical Autologous Biologics Products Offered
Table 23. Medical Autologous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Medical Autologous Biologics Sales by Geographic Region (2021-2026) & (Kg)
Table 27. Global Medical Autologous Biologics Sales Market Share Geographic Region (2021-2026)
Table 28. Global Medical Autologous Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Medical Autologous Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Medical Autologous Biologics Sales by Country/Region (2021-2026) & (Kg)
Table 31. Global Medical Autologous Biologics Sales Market Share by Country/Region (2021-2026)
Table 32. Global Medical Autologous Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Medical Autologous Biologics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 35. Americas Medical Autologous Biologics Sales Market Share by Country (2021-2026)
Table 36. Americas Medical Autologous Biologics Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 38. Americas Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 39. APAC Medical Autologous Biologics Sales by Region (2021-2026) & (Kg)
Table 40. APAC Medical Autologous Biologics Sales Market Share by Region (2021-2026)
Table 41. APAC Medical Autologous Biologics Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 43. APAC Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 44. Europe Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 45. Europe Medical Autologous Biologics Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 47. Europe Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 48. Middle East & Africa Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 49. Middle East & Africa Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 51. Middle East & Africa Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Medical Autologous Biologics
Table 53. Key Market Challenges & Risks of Medical Autologous Biologics
Table 54. Key Industry Trends of Medical Autologous Biologics
Table 55. Medical Autologous Biologics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Medical Autologous Biologics Distributors List
Table 58. Medical Autologous Biologics Customer List
Table 59. Global Medical Autologous Biologics Sales Forecast by Region (2027-2032) & (Kg)
Table 60. Global Medical Autologous Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 62. Americas Medical Autologous Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Medical Autologous Biologics Sales Forecast by Region (2027-2032) & (Kg)
Table 64. APAC Medical Autologous Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 66. Europe Medical Autologous Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 68. Middle East & Africa Medical Autologous Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Medical Autologous Biologics Sales Forecast by Type (2027-2032) & (Kg)
Table 70. Global Medical Autologous Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Medical Autologous Biologics Sales Forecast by Application (2027-2032) & (Kg)
Table 72. Global Medical Autologous Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Vericel Corporation Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 74. Vericel Corporation Medical Autologous Biologics Product Portfolios and Specifications
Table 75. Vericel Corporation Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. Vericel Corporation Main Business
Table 77. Vericel Corporation Latest Developments
Table 78. BioTime Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 79. BioTime Medical Autologous Biologics Product Portfolios and Specifications
Table 80. BioTime Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. BioTime Main Business
Table 82. BioTime Latest Developments
Table 83. Pharmicell Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 84. Pharmicell Medical Autologous Biologics Product Portfolios and Specifications
Table 85. Pharmicell Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. Pharmicell Main Business
Table 87. Pharmicell Latest Developments
Table 88. BrainStorm Cell Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 89. BrainStorm Cell Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 90. BrainStorm Cell Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. BrainStorm Cell Therapeutics Main Business
Table 92. BrainStorm Cell Therapeutics Latest Developments
Table 93. Opexa Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 94. Opexa Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 95. Opexa Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. Opexa Therapeutics Main Business
Table 97. Opexa Therapeutics Latest Developments
Table 98. Sartorius Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. Sartorius Medical Autologous Biologics Product Portfolios and Specifications
Table 100. Sartorius Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. Sartorius Main Business
Table 102. Sartorius Latest Developments
Table 103. Neostem Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. Neostem Medical Autologous Biologics Product Portfolios and Specifications
Table 105. Neostem Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. Neostem Main Business
Table 107. Neostem Latest Developments
Table 108. Dendreon Corporation Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Dendreon Corporation Medical Autologous Biologics Product Portfolios and Specifications
Table 110. Dendreon Corporation Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Dendreon Corporation Main Business
Table 112. Dendreon Corporation Latest Developments
Table 113. Regenexx Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. Regenexx Medical Autologous Biologics Product Portfolios and Specifications
Table 115. Regenexx Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. Regenexx Main Business
Table 117. Regenexx Latest Developments
Table 118. Cytori Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. Cytori Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 120. Cytori Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. Cytori Therapeutics Main Business
Table 122. Cytori Therapeutics Latest Developments
Table 1. Medical Autologous Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Autologous Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adipose Tissue
Table 4. Major Players of Plasma
Table 5. Major Players of Others
Table 6. Global Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 7. Global Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Table 8. Global Medical Autologous Biologics Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Autologous Biologics Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Autologous Biologics Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Medical Autologous Biologics Sale by Application (2021-2026) & (Kg)
Table 12. Global Medical Autologous Biologics Sale Market Share by Application (2021-2026)
Table 13. Global Medical Autologous Biologics Revenue by Application (2021-2026) & ($ million)
Table 14. Global Medical Autologous Biologics Revenue Market Share by Application (2021-2026)
Table 15. Global Medical Autologous Biologics Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Medical Autologous Biologics Sales by Company (2021-2026) & (Kg)
Table 17. Global Medical Autologous Biologics Sales Market Share by Company (2021-2026)
Table 18. Global Medical Autologous Biologics Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Medical Autologous Biologics Revenue Market Share by Company (2021-2026)
Table 20. Global Medical Autologous Biologics Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Medical Autologous Biologics Producing Area Distribution and Sales Area
Table 22. Players Medical Autologous Biologics Products Offered
Table 23. Medical Autologous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Medical Autologous Biologics Sales by Geographic Region (2021-2026) & (Kg)
Table 27. Global Medical Autologous Biologics Sales Market Share Geographic Region (2021-2026)
Table 28. Global Medical Autologous Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Medical Autologous Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Medical Autologous Biologics Sales by Country/Region (2021-2026) & (Kg)
Table 31. Global Medical Autologous Biologics Sales Market Share by Country/Region (2021-2026)
Table 32. Global Medical Autologous Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Medical Autologous Biologics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 35. Americas Medical Autologous Biologics Sales Market Share by Country (2021-2026)
Table 36. Americas Medical Autologous Biologics Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 38. Americas Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 39. APAC Medical Autologous Biologics Sales by Region (2021-2026) & (Kg)
Table 40. APAC Medical Autologous Biologics Sales Market Share by Region (2021-2026)
Table 41. APAC Medical Autologous Biologics Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 43. APAC Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 44. Europe Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 45. Europe Medical Autologous Biologics Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 47. Europe Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 48. Middle East & Africa Medical Autologous Biologics Sales by Country (2021-2026) & (Kg)
Table 49. Middle East & Africa Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Medical Autologous Biologics Sales by Type (2021-2026) & (Kg)
Table 51. Middle East & Africa Medical Autologous Biologics Sales by Application (2021-2026) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Medical Autologous Biologics
Table 53. Key Market Challenges & Risks of Medical Autologous Biologics
Table 54. Key Industry Trends of Medical Autologous Biologics
Table 55. Medical Autologous Biologics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Medical Autologous Biologics Distributors List
Table 58. Medical Autologous Biologics Customer List
Table 59. Global Medical Autologous Biologics Sales Forecast by Region (2027-2032) & (Kg)
Table 60. Global Medical Autologous Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 62. Americas Medical Autologous Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Medical Autologous Biologics Sales Forecast by Region (2027-2032) & (Kg)
Table 64. APAC Medical Autologous Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 66. Europe Medical Autologous Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Medical Autologous Biologics Sales Forecast by Country (2027-2032) & (Kg)
Table 68. Middle East & Africa Medical Autologous Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Medical Autologous Biologics Sales Forecast by Type (2027-2032) & (Kg)
Table 70. Global Medical Autologous Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Medical Autologous Biologics Sales Forecast by Application (2027-2032) & (Kg)
Table 72. Global Medical Autologous Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Vericel Corporation Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 74. Vericel Corporation Medical Autologous Biologics Product Portfolios and Specifications
Table 75. Vericel Corporation Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. Vericel Corporation Main Business
Table 77. Vericel Corporation Latest Developments
Table 78. BioTime Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 79. BioTime Medical Autologous Biologics Product Portfolios and Specifications
Table 80. BioTime Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. BioTime Main Business
Table 82. BioTime Latest Developments
Table 83. Pharmicell Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 84. Pharmicell Medical Autologous Biologics Product Portfolios and Specifications
Table 85. Pharmicell Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. Pharmicell Main Business
Table 87. Pharmicell Latest Developments
Table 88. BrainStorm Cell Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 89. BrainStorm Cell Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 90. BrainStorm Cell Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. BrainStorm Cell Therapeutics Main Business
Table 92. BrainStorm Cell Therapeutics Latest Developments
Table 93. Opexa Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 94. Opexa Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 95. Opexa Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. Opexa Therapeutics Main Business
Table 97. Opexa Therapeutics Latest Developments
Table 98. Sartorius Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. Sartorius Medical Autologous Biologics Product Portfolios and Specifications
Table 100. Sartorius Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. Sartorius Main Business
Table 102. Sartorius Latest Developments
Table 103. Neostem Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. Neostem Medical Autologous Biologics Product Portfolios and Specifications
Table 105. Neostem Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. Neostem Main Business
Table 107. Neostem Latest Developments
Table 108. Dendreon Corporation Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Dendreon Corporation Medical Autologous Biologics Product Portfolios and Specifications
Table 110. Dendreon Corporation Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Dendreon Corporation Main Business
Table 112. Dendreon Corporation Latest Developments
Table 113. Regenexx Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. Regenexx Medical Autologous Biologics Product Portfolios and Specifications
Table 115. Regenexx Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. Regenexx Main Business
Table 117. Regenexx Latest Developments
Table 118. Cytori Therapeutics Basic Information, Medical Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. Cytori Therapeutics Medical Autologous Biologics Product Portfolios and Specifications
Table 120. Cytori Therapeutics Medical Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. Cytori Therapeutics Main Business
Table 122. Cytori Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Autologous Biologics
Figure 2. Medical Autologous Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Autologous Biologics Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global Medical Autologous Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Autologous Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Autologous Biologics Sales Market Share by Country/Region (2025)
Figure 10. Medical Autologous Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Adipose Tissue
Figure 12. Product Picture of Plasma
Figure 13. Product Picture of Others
Figure 14. Global Medical Autologous Biologics Sales Market Share by Type in 2026
Figure 15. Global Medical Autologous Biologics Revenue Market Share by Type (2021-2026)
Figure 16. Medical Autologous Biologics Consumed in Hospitals
Figure 17. Global Medical Autologous Biologics Market: Hospitals (2021-2026) & (Kg)
Figure 18. Medical Autologous Biologics Consumed in Research Center
Figure 19. Global Medical Autologous Biologics Market: Research Center (2021-2026) & (Kg)
Figure 20. Medical Autologous Biologics Consumed in Others
Figure 21. Global Medical Autologous Biologics Market: Others (2021-2026) & (Kg)
Figure 22. Global Medical Autologous Biologics Sale Market Share by Application (2025)
Figure 23. Global Medical Autologous Biologics Revenue Market Share by Application in 2026
Figure 24. Medical Autologous Biologics Sales by Company in 2026 (Kg)
Figure 25. Global Medical Autologous Biologics Sales Market Share by Company in 2026
Figure 26. Medical Autologous Biologics Revenue by Company in 2026 ($ millions)
Figure 27. Global Medical Autologous Biologics Revenue Market Share by Company in 2026
Figure 28. Global Medical Autologous Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Medical Autologous Biologics Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 31. Americas Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 32. APAC Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 33. APAC Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 34. Europe Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 35. Europe Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 37. Middle East & Africa Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 38. Americas Medical Autologous Biologics Sales Market Share by Country in 2026
Figure 39. Americas Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Figure 40. Americas Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 41. Americas Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 42. United States Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Medical Autologous Biologics Sales Market Share by Region in 2026
Figure 47. APAC Medical Autologous Biologics Revenue Market Share by Region (2021-2026)
Figure 48. APAC Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 49. APAC Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 50. China Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. India Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Medical Autologous Biologics Sales Market Share by Country in 2026
Figure 58. Europe Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Figure 59. Europe Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 60. Europe Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 61. Germany Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 62. France Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Medical Autologous Biologics Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 69. Egypt Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Medical Autologous Biologics in 2026
Figure 75. Manufacturing Process Analysis of Medical Autologous Biologics
Figure 76. Industry Chain Structure of Medical Autologous Biologics
Figure 77. Channels of Distribution
Figure 78. Global Medical Autologous Biologics Sales Market Forecast by Region (2027-2032)
Figure 79. Global Medical Autologous Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Medical Autologous Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Medical Autologous Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Medical Autologous Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Medical Autologous Biologics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Autologous Biologics
Figure 2. Medical Autologous Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Autologous Biologics Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global Medical Autologous Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Autologous Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Autologous Biologics Sales Market Share by Country/Region (2025)
Figure 10. Medical Autologous Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Adipose Tissue
Figure 12. Product Picture of Plasma
Figure 13. Product Picture of Others
Figure 14. Global Medical Autologous Biologics Sales Market Share by Type in 2026
Figure 15. Global Medical Autologous Biologics Revenue Market Share by Type (2021-2026)
Figure 16. Medical Autologous Biologics Consumed in Hospitals
Figure 17. Global Medical Autologous Biologics Market: Hospitals (2021-2026) & (Kg)
Figure 18. Medical Autologous Biologics Consumed in Research Center
Figure 19. Global Medical Autologous Biologics Market: Research Center (2021-2026) & (Kg)
Figure 20. Medical Autologous Biologics Consumed in Others
Figure 21. Global Medical Autologous Biologics Market: Others (2021-2026) & (Kg)
Figure 22. Global Medical Autologous Biologics Sale Market Share by Application (2025)
Figure 23. Global Medical Autologous Biologics Revenue Market Share by Application in 2026
Figure 24. Medical Autologous Biologics Sales by Company in 2026 (Kg)
Figure 25. Global Medical Autologous Biologics Sales Market Share by Company in 2026
Figure 26. Medical Autologous Biologics Revenue by Company in 2026 ($ millions)
Figure 27. Global Medical Autologous Biologics Revenue Market Share by Company in 2026
Figure 28. Global Medical Autologous Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Medical Autologous Biologics Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 31. Americas Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 32. APAC Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 33. APAC Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 34. Europe Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 35. Europe Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Medical Autologous Biologics Sales 2021-2026 (Kg)
Figure 37. Middle East & Africa Medical Autologous Biologics Revenue 2021-2026 ($ millions)
Figure 38. Americas Medical Autologous Biologics Sales Market Share by Country in 2026
Figure 39. Americas Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Figure 40. Americas Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 41. Americas Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 42. United States Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Medical Autologous Biologics Sales Market Share by Region in 2026
Figure 47. APAC Medical Autologous Biologics Revenue Market Share by Region (2021-2026)
Figure 48. APAC Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 49. APAC Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 50. China Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. India Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Medical Autologous Biologics Sales Market Share by Country in 2026
Figure 58. Europe Medical Autologous Biologics Revenue Market Share by Country (2021-2026)
Figure 59. Europe Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 60. Europe Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 61. Germany Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 62. France Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Medical Autologous Biologics Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Medical Autologous Biologics Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Medical Autologous Biologics Sales Market Share by Application (2021-2026)
Figure 69. Egypt Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Medical Autologous Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Medical Autologous Biologics in 2026
Figure 75. Manufacturing Process Analysis of Medical Autologous Biologics
Figure 76. Industry Chain Structure of Medical Autologous Biologics
Figure 77. Channels of Distribution
Figure 78. Global Medical Autologous Biologics Sales Market Forecast by Region (2027-2032)
Figure 79. Global Medical Autologous Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Medical Autologous Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Medical Autologous Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Medical Autologous Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Medical Autologous Biologics Revenue Market Share Forecast by Application (2027-2032)
